| Patterns of adherence to oral atypical antipsychotics among patients diagnosed with schizophrenia JP MacEwan, FM Forma, J Shafrin, A Hatch, DN Lakdawalla, ... Journal of managed care & specialty pharmacy 22 (11), 1349-1361, 2016 | 55 | 2016 |
| Economic burden of multiple myeloma among patients in successive lines of therapy in the United States JP MacEwan, K Batt, W Yin, D Peneva, S Sison, S Vine, C Chen Leukemia & lymphoma 59 (4), 941-949, 2018 | 45 | 2018 |
| Hospital readmission rates among patients with schizophrenia treated with long-acting injectables or oral antipsychotics JP MacEwan, SA Kamat, RA Duffy, S Seabury, JW Chou, SN Legacy, ... Psychiatric Services 67 (11), 1183-1188, 2016 | 45 | 2016 |
| The consequences of obesity for the external costs of public health insurance in the United States JP MacEwan, JM Alston, AM Okrent Applied Economic Perspectives and Policy 36 (4), 696-716, 2014 | 42 | 2014 |
| Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995–2007 W Stevens, TJ Philipson, ZM Khan, JP MacEwan, MT Linthicum, ... Health affairs 34 (4), 562-570, 2015 | 31 | 2015 |
| Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators JP Jansen, D Incerti, A Mutebi, D Peneva, JP MacEwan, B Stolshek, ... Journal of Medical Economics 20 (7), 703-714, 2017 | 28 | 2017 |
| The economics of obesity and related policy JM Alston, JP MacEwan, AM Okrent Annual Review of Resource Economics 8 (1), 443-465, 2016 | 28 | 2016 |
| Pharmaceutical innovation in the treatment of schizophrenia and mental disorders compared with other diseases JP MacEwan, S Seabury, MS Aigbogun, S Kamat, E van Eijndhoven, ... Innovations in Clinical Neuroscience 13 (7-8), 17, 2016 | 28 | 2016 |
| The effects of prices, advertising, expenditures, and demographics on demand for nonalcoholic beverages AM Okrent, JP MacEwan Agricultural and Resource Economics Review 43 (1), 31-52, 2014 | 27 | 2014 |
| Evaluating expected costs and benefits of granting access to new treatments on the basis of progression-free survival in non–small-cell lung cancer DN Lakdawalla, JW Chou, MT Linthicum, JP MacEwan, J Zhang, ... JAMA oncology 1 (2), 196-202, 2015 | 25 | 2015 |
| Antiobesity medication use among overweight and obese adults in the United States: 2015–2018 J MacEwan, H Kan, K Chiu, JL Poon, S Shinde, NN Ahmad Endocrine Practice 27 (11), 1139-1148, 2021 | 20 | 2021 |
| Medication adherence patterns among patients with multiple serious mental and physical illnesses JP MacEwan, AR Silverstein, J Shafrin, DN Lakdawalla, A Hatch, ... Advances in therapy 35, 671-685, 2018 | 20 | 2018 |
| Physician and patient preferences for nonvalvular atrial fibrillation therapies J Shafrin, A Bruno, JP MacEwan, A Campinha-Bacote, J Trocio, M Shah, ... Value in Health 19 (4), 451-459, 2016 | 20 | 2016 |
| Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016 JP MacEwan, S Dennen, R Kee, F Ali, J Shafrin, K Batt Journal of Medical Economics 23 (12), 1558-1569, 2020 | 16 | 2020 |
| A comparison of diagnosed and undiagnosed diabetes patients and labor supply T Minor, JP MacEwan Economics & Human Biology 20, 14-25, 2016 | 16 | 2016 |
| The value of progression-free survival in metastatic breast cancer: results from a survey of patients and providers JP MacEwan, J Doctor, K Mulligan, SG May, K Batt, C Zacker, ... MDM Policy & Practice 4 (1), 2381468319855386, 2019 | 15 | 2019 |
| Effects of US public agricultural R&D on US obesity and its social costs JM Alston, JP MacEwan, AM Okrent Applied Economic Perspectives and Policy 38 (3), 492-520, 2016 | 14 | 2016 |
| Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis E van Eijndhoven, M Brauer, R Kee, J MacEwan, L Mucha, SL Wong, ... Journal of Medical Economics 23 (5), 474-483, 2020 | 10 | 2020 |
| What do pharmaceuticals really cost in the long run D Lakdawalla, JP MacEwan, R Dubois, K Westrich, M Berdud, A Towse Am J Manag Care 23 (8), 488-493, 2017 | 10 | 2017 |
| Incremental health care costs of anxiety and depression among Medicare beneficiaries with cancer K Birch, S Chung, SR Zion, JP MacEwan, MJ Malecki JCO Oncology Practice 19 (5), e660-e671, 2023 | 8 | 2023 |
